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SARCOMA of the breast is a rare tumour, accounting for between 0.12% (1 in
804 tumours, Willis, 1960a) and 3% (Illingworth and Dick, 1941) of all breast
tumours. Although a few series have been reported in recent years in the Ameri-
can literature (Hill and Stout, 1942; Treves and Sunderland, 1951; Lester and
Stout. 1954; Ariel, 1961), only one series (Curran and Dodge, 1962) and a few
isolated cases have been reported from Great Britain.
MATERIAL AND METHODS
The present series has been collected from the records of the Birmingham
Regional Histological Collection between 1953-65. All tumours that had been
coded as malignant nonepithelial tumours were reviewed. After possible ana-
plastic carcinomas had been excluded there were 22 spindle cell sarcomas in
females, 2 fibroadenomas with possible sarcomatous change in the fibrous com-
ponent, and aspindle cell sarcoma of breast in a boy of 12. There were no other
types of sarcoma. In the years 1953-64 for which records are complete, the
sarcomas accounted for 0.14% of all malignant breast tumours.
The clinical and follow-up details were obtained from the Birmingham Regional
Cancer Registry and these with the pathological data are summarised in Table I.
TERMINOLOGY AND CLASSIFICATION
In the past there has been considerable confusion over the terminology ofthese
tumours, particularly in the use of the terms cystosarcoma phyllodes and adeno-
fibrosarcoma. Johannes Muller (1838) first used the term cystosarcoma phyl-
lodes to describe a giant fibroadenoma with a leaf like cut surface. Treves and
Sunderland used the term to describe a fibroadenoma which showed an increase in
the amount andcellularity ofthe fibrous component, but which was not necessarily
large in overall size. They subdivided them histologically into benign and malig-
nant forms. Many surgeons and pathologists think ofthese tumours as essentially
benign, as originally described by Muller, but others as essentially malignant in
view of the term cystosarcoma. The term adenofibrosarcoma has been used
either synonymously with cystosarcoma phyllodes (Hill and Stout, 1942), or to
describe a sarcoma arising in a fibroadenoma (Rogers and Flo, 1942) or for fibro-
sarcomas of breast containing numerous glandular elements, but with no evidence
of benign fibroadenoma (Curran and Dodge, 1962). The majority of spindle cell
sarcomas of breast are thought to arise in a pre-existing fibroadenoma (D'Aunoy
and Wright, 1930; Treves and Sunderland, 1951; Willis, 1960a; and Stewart,F. J. FAWCETT
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1950). The present series has been divided into four groups, avoiding the old
terminology. They are:
I. Sarcomas that have definitely arisen in a pre-existing fibroadenoma.
II. Sarcomas possibly arising in a fibroadenoma.
III. Sarcomas in which there is no evidence of a pre-existing fibroadenoma.
IV. Fibroadenoma in which the fibrous component is possibly sarcomatous.
Tumours were placed in group II, if they had a long history of a lump in the
breast, the typical macroscopic appearance seen in group I or contained glandular
elements but no fibroadenoma.
The benign fibroadenomatous element may be present only in a very small
part of the sarcoma and be missed if insufficient blocks are examined. As a
result ofthis, in a retrospective survey with a limited number ofsections or blocks,
the classification of some cases must be arbitrary. If more blocks had been
examined, a benign fibroadenoma would probably have been found in many ofthe
cases in groups II and III, and possibly frankly sarcomatous areas in the tumours
of group IV.
MACROSCOPIC AND HISTOLOGICAL APPEARANCE
Group I-Sarcomas definitely arising in a fibroadenoma
The 11 tumours in this group varied in size from 3-18 cm. diameter. They
were either entirely or partly encapsulated and the cut surface had a papillary or
leaf-like appearance with numerous clefts (Fig. 1). Many tumours showed exten-
sive necrosis and the larger ones tended to ulcerate through the skin.
Histologically the tumour had the appearance of a fibroadenoma, usually of
mixed intra- and pericanalicular type, but the fibrous component was increased,
very cellular and pleomorphic, and consisted predominantly of spindle cells and
many myxomatous areas (Fig. 2 and 3). Mitotic activity was variable.
Two types of giant cells were seen. The first were tumour giant cells with
a few irregular hyperchromatic nuclei (Fig. 4) and the second type resembled
osteoclasts (Fig. 5) with numerous regular nuclei. The two tumours which
contained the osteoclast-like giant cells also showed seams of osteoid (Fig. 5)
and one contained cartilage (Fig. 6). These are considered separately with two
other similar tumours.
The epithelial elements showed areas ofproliferation and squamous metaplasia
(Fig. 7) but never carcinoma.
Group II-Sarcomas possibly arising in a fibroadenoma
The 7 tumours in this group varied in size from 3-6 cm. Some had the typical
macroscopic appearance seen in the first group, others a firm homogeneous cut
surface, but most of the tumours were partly necrotic. The majority contained
glandular elements surrounded by pleomorphic spindle cells and some tumour
giant cells (Fig. 8). One of the tumours contained osteoclast-like giant cells and
seams of osteoid.
Group III-Sarcomas in which there was no evidence of pre-existing fibroadenoma
The 4 tumours from female patients varied in size between 5 cm. and 18 x 15
x 10 cm. and had a firm white cut surface which resembled fibrosarcomas else-
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where inthe body. The histological appearance wasthat ofa spindle cell sarcoma,
devoid of epithelial elements, but one of the tumours contained osteoclast-like
giant cells. The largest tumour in this group arose in a woman with neurofibro-
matosis (case No. 21), but the histological features in the material available were
those of a spindle cell sarcoma without the specific features ofneurofibrosarcoma
(Fig. 9)
The tumour of the 12-year-old boy was a spindle cell sarcoma arising below
the nipple, but with no epithelial elements.
Group IV-Fibroadenomas with possible sarcomatous change in fibrous component
Both these tumours had the typical macroscopic appearance seen in group I,
with a cauliflower-like cut surface. The histological appearance was that of a
fibroadenoma but with an increase in the amount and cellularity of the fibrous
component, with some pleomorphism but which was not considered frankly
malignant.
Sarcomas containing osteoclast-like giant cells
Two ofthese tumours were definitely arising in fibroadenomas (cases 1 and 3),
a third contained glandular elements suggesting that it had arisen in a fibro-
adenoma (case 17), and in the fourth case (No. 20), there was no evidence of
a pre-existing fibroadenoma. They varied in size from 4-18 cm. diameter.
Histologically, there were numerous multinucleated giant cells interspersed
with spindle and ovoid mononuclear cells. All the tumours contained bands of
eosinophilic material resembling osteoid and the giant cells were often in lacunae
within these bands (Fig. 5). One of the tumours contained definite areas of
cartilage (Fig. 6) and another had areas somewhat resembling cartilage. There
were foci ofcalcification within the cartilage but no ossification. Paraffin sections
from these four tumours were stained by Gomori's methods for acid and alkaline
phosphatases and Pearse's (1960) method for non-specific esterases. The giant
cells showed acid phosphatase activity in the cytoplasm (Fig. 10), and some ofthe
EXPLANATION OF PLATES
FIG. 1.-Typical macroscopic appearance of sarcoma in group I. (natural size).
FIG. 2.-Microscopic appearance of tumour shown in Fig. 1. Haematoxylin and eosin, x 30.
FIG. 3.-Myxomatous area in sarcoma in group I. Haematoxylin and eosin, x 120.
FIG. 4.-Spindle cells and giant cells in same tumour as Fig. 3. Haematoxylin and eosin,
x 120.
FIG. 5.-Osteoclast like giant cells in lacuna of osteoid. Weigerts iron haematoxylin and
Van Gieson, x 300.
FIG. 6.-Osteoclastic sarcoma of breast, showing area of cartilage surrounded by osteoclast
like giant cells and spindle cells. Haematoxylin and eosin, x 120.
FIG. 7.-Area ofsquamousmetaplasia ofepithelium in tumourshown in Fig. 1. Haematoxylin
and eosin, x 120.
FIG. 8.-Tumour ingroup II, showingglandularelement, spindle cells andgiant cells. Haema-
toxylin and eosin, x 120.
FIG. 9.-Spindle cell sarcoma in woman with Von Recklinghausen's disease (case No. 21).
Haematoxylin and eosin, x 120.
FIG. 10.-Osteoclastic sarcoma, showing acid phosphatase activity in cytoplasm ofgiant cells.
Gomori's acid phosphatase, x 300.
FIG. 11.-Osteoclastic sarcoma, showing alkaline phosphatase activity in interposed cells.
Gomori's alkaline phosphatase, x 300.
FIG. 12.-Sarcoma invading blood vessel (case No. 2). Haematoxylin and eosin, x 48.
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mononuclear cells alkaline phosphatase activity in their nuclei and cytoplasm
(Fig. 11), which was absent in control sections with substrate omitted. Frozen
sections ofnormal breast tissue showed alkaline phosphatase activity in the epi-
thelium and "myoepithelium ". There was no esterase activity in the tumours.
None of these patients had tumours of bone.
AGE INCIDENCE AND DURATION
All the female cases presented after the menopause with three exceptions,
a girl of 19 years (case 7) in group I, a woman 31 years (case 18) in group II and
a woman 37 years (case,25) in group IV. The length of time which the patient
had noticed a lump, varied from one week to 35 years, the time interval being in
general longest in group I and shortest in group III, and the " osteoclastic "
tumours. Thesolitarymalecase occurred in a boyof 12 years, but the duration of
the lump was not recorded.
FOLLOW-UP DETAILS
In the 11 cases of group I, 5 died from sarcomatosis between 8 months and
4 years 9 months after primary excision, and case 3 had a local recurrence at
3 months.
Case 2 presented with a sarcoma of left breast which was excised by simple
mastectomy. Histology showed the sarcoma invading blood vessels (Fig. 11) and
3 months later a sarcoma appeared in the right breast. This case has been pre-
viously reported (Notley and Griffiths 1965). Case 5 died of congestive cardiac
failure two years after mastectomy with no clinical evidence oflocal recurrence or
metastasis, but there was no necropsy. The remaining 5 cases are alive and
apparently free from recurrence 4 months, 2, 3, 6 and 8 years respectively after
mastectomy.
In group II, 5 ofthe 7 cases died ofsarcomatosis between 7 months and 4 years
8 months after mastectomy. Two cases, 12 and 13, had a local recurrence 3 and
4 monthsrespectively following excision. The other 2 cases are alive and well 12
months and 19 months after mastectomy. All the 4 cases in women in group III
died, 3 of sarcomatosis between 8 and 14 months after excision, 2 of whom had
a local recurrence 4 months after the original excision; the fourth died ofcerebral
thrombosis 9 years after primary excision, with no clinical evidence ofrecurrence.
Case 21 had a metastasis clinically in the axillary nodes but no histological confirm-
ation. This, the only possible example of lymph node metastasis, was not histo-
logically proven. Metastases in all the fatal cases were to lung and mediastinum
with metastasis in the liver (case 21) and brain (case 1) in solitary cases.
The 12-year-old boy is alive and well 5 years after his operation. Both the
cases in group IV were alive and well 2 years after local mastectomy in one case
and wedge resection in the other.
DISCUSSION
The age distribution was similar to that found by Curran and Dodge (1962).
All but 2 of the female cases presented after the menopause. Two of the cases
in group I had noticed a lump in the breast for 19 years (case 10) and 35 years
(case 11), though the lump in the latter case had enlarged after the menopause.
The two exceptions, cases 7 and 18 were aged 19 and 31 years respectively. Most
291F. J. FAWCETT
benign fibroadenomas occur well before the menopause and regress at that time,
whereas in these tumours the malignant transformation occurs after the meno-
pause, suggesting hormonal imbalance as a possible aetiological factor.
Cartilaginous and bony metaplasia of the fibrous component is a rare occurr-
ence in benign fibroadenomas in women (Willis, 1960a) but frequently occurs in
fibroadenomas and sarcomas arising in fibroadenomas of bitches (Cotchin, 1958).
(otchin noticed that the polyhedral cells in similar giant cell tumours of bitches
showed alkaline phosphatase activity and suggested that this indicated that they
may be derived from myoepithelial cells of the breast which had similar alkaline
phosphatase activity.
Frozen sections of human breast tissue confirmed that there was alkaline
phosphatase activity in myoepithelium and also showed activity in the epithelium
of breast ducts in the breast. It is possible that either the myoepithelium or
epithelium of the ducts may be involved, as well as the fibrous component in
these osteoclastic tumours.
It is interesting to note, that the osteoclastomas studied histochemically by
Pepler (1958) had similar properties to these tumours, with acid phosphatase
activity in the giant cells and alkaline phosphatase in the " stromal cells ".
Willis (1962b) noted that there was high alkaline phosphatase activity in the
mucosa of colon, which is the most frequent source of carcinomas with extensive
and direct stromal ossification. Although bone was not present in these four
" osteoclastic " tumours, bony metaplasia has been reported in such tumours
(Rottino and Howley, 1945).
PROGNOSIS AND TREATMENT
Thirteen of the 22 women died with sarcomatosis, all in less than 5 years.
Five of these had had local recurrences within 12 months of the first operation.
One patient died of congestive cardiac failure 2 years after excision and another
9 years later, with cerebral thrombosis, neither of whom appeared to have had a
recurrence. The remaining 7 patients are alive and well, though only 2 have so
far survived 5 years. These figures suggest that sarcoma ofbreast carried a graver
prognosis than suggested by the figures of Curran and Dodge of 8 deaths from
sarcomatosis in 39 sarcomas of breast. Treves and Sunderland (1951) found that
8 of their 18 histologically malignant cystosarcomas phyllodes ultimately died of
sarcomatosis. The prognosis did not appear to be related to treatment. Simple
mastectomy with excision of deep fascia seemed to be adequate in view of the
absence of metastases to axillary lymph nodes, (with the possibJe exception of
case 21). Local excision (cases 3 and 13) was followed by local recurrence in 3
and 4 months respectively. Radiotherapy and chemotherapy, which were used
mainly for recurrences and metastases, appeared to have no beneficial effect. It
is not possible to assess the effects of age on prognosis in such a series, but of the
patients over 70 years, case 22, aged 83, died 9 years later without evidence of
recurrence, and case 5, aged 73, died 2 years later, apparently free from tumour.
The younger patients, cases 7 and 18 have presented too recently for comment.
There is no correlation between size and survival, but the 2 cases (10 and 11)
who presented with a long history, 19 and 35 years, are alive 6 and 8 years later.
Treves and Sunderland found that 61.1l% of their malignant cystosarcomas phyl-
lodes had not borne children and none of the metastasising cases had had a full
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term pregnancy. None of the 6 patients in groups I and II (of the present series)
in which the parity state was recorded, had borne children, and 3 of them died
with sarcomatosis. In group III however, 2 had borne children, and one had not.
The histological assessment of malignancy appears to be difficult. The pres-
ence oftumour giant cells does not necessarily indicate a poor prognosis. Three of
the 4 tumours containing osteoid and osteoclast-like giant cells died within 19
months and the fourth is alive andwell only 12 months aftermastectomy. Rottino
and Howley (1945) in their review ofthe literature, found that 16 ofthe 25 women
with osteoid sarcomas of breast had died within 12 months.
Case 2, the only case in which invasion of blood vessels was seen (Fig. 12),
presented with a sarcoma ofthe opposite breast 3 months later and died 9 months
after being first seen. Both the patients with possibly sarcomatous tumours
placed in group IV, are alive and well, but cases have been reported that were
considered to be histologically benign and later presented with metastases (Lester
and Stout, 1954; Collins and Dodge, 1959). This further stresses the importance
of examining many blocks from fibroadenomas histologically, particularly in
tumours presenting after the menopause.
SUMMARY
The clinical and pathological findings in 23 sarcomas of breast and 2 fibro-
adenomaswith possible sarcomatous change, are presented. Allthe tumours were
of spindle cell type and 4 tumours contained osteoid and giant cells resembling
osteoclasts. The classification used is based on their origin from benign fibroad-
enomas and the terms cystosarcoma phyllodes and adenofibrosarcoma are avoided.
The follow-up data suggest that this tumour has a worse prognosis than
previously considered and that fibroadenomas presenting after the patient's meno-
pause should be closely examined for evidence of malignancy.
I wish to acknowledge the help and co-operation of Dr. S. C. Dyke, Curator
of the Regional Histological Collection, and the pathologists of the Birmingham
Regional Hospital Board, who have kindly allowed me access to their material.
I also wish to thank Dr. J. A. H. Waterhouse and Miss D. J. Powell, of the
Birmingham Regional Cancer Registry.
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